BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33298977)

  • 1. Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis.
    Counoupas C; Ferrell KC; Ashhurst A; Bhattacharyya ND; Nagalingam G; Stewart EL; Feng CG; Petrovsky N; Britton WJ; Triccas JA
    NPJ Vaccines; 2020 Nov; 5(1):105. PubMed ID: 33298977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta inulin-based adjuvants promote the generation of polyfunctional CD4
    Counoupas C; Pinto R; Nagalingam G; Britton WJ; Petrovsky N; Triccas JA
    Sci Rep; 2017 Aug; 7(1):8582. PubMed ID: 28819247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity.
    Quan DH; Counoupas C; Nagalingam G; Pinto R; Petrovsky N; Britton WJ; Triccas JA
    Vaccine; 2021 Apr; 39(14):1990-1996. PubMed ID: 33714652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Adjuvants Enhance Recombinant Protein Vaccine Protection against Fungal Infection.
    Wüthrich M; Dobson HE; Ledesma Taira C; Okaa UJ; Dos Santos Dias L; Isidoro-Ayza M; Petrovsky N; Klein BS
    mBio; 2021 Aug; 12(4):e0201821. PubMed ID: 34399628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung IL-17A-Producing CD4
    Stewart EL; Counoupas C; Quan DH; Wang T; Petrovsky N; Britton WJ; Triccas JA
    Vaccines (Basel); 2024 Jan; 12(2):. PubMed ID: 38400112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of recombinant BCG over-expressing protective, stage-specific antigens of Mycobacterium tuberculosis.
    Counoupas C; Pinto R; Nagalingam G; Britton WJ; Triccas JA
    Vaccine; 2018 May; 36(19):2619-2629. PubMed ID: 29627232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-23 instructs protective multifunctional CD4 T cell responses after immunization with the Mycobacterium tuberculosis subunit vaccine H1 DDA/TDB independently of interleukin-17A.
    Ritter K; Behrends J; Erdmann H; Rousseau J; Hölscher A; Volz J; Prinz I; Lindenstrøm T; Hölscher C
    J Mol Med (Berl); 2021 Nov; 99(11):1585-1602. PubMed ID: 34351501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection.
    Rodriguez-Del Rio E; Marradi M; Calderon-Gonzalez R; Frande-Cabanes E; Penadés S; Petrovsky N; Alvarez-Dominguez C
    Vaccine; 2015 Mar; 33(12):1465-73. PubMed ID: 25659269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis.
    Perdomo C; Zedler U; Kühl AA; Lozza L; Saikali P; Sander LE; Vogelzang A; Kaufmann SH; Kupz A
    mBio; 2016 Nov; 7(6):. PubMed ID: 27879332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection.
    Honda-Okubo Y; Ong CH; Petrovsky N
    Vaccine; 2015 Sep; 33(38):4892-900. PubMed ID: 26232344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.
    Orr MT; Beebe EA; Hudson TE; Argilla D; Huang PW; Reese VA; Fox CB; Reed SG; Coler RN
    Vaccine; 2015 Nov; 33(48):6570-8. PubMed ID: 26541135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.
    Kolibab K; Yang A; Derrick SC; Waldmann TA; Perera LP; Morris SL
    Clin Vaccine Immunol; 2010 May; 17(5):793-801. PubMed ID: 20357059
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Counoupas C; Pinto R; Nagalingam G; Hill-Cawthorne GA; Feng CG; Britton WJ; Triccas JA
    NPJ Vaccines; 2016; 1():16012. PubMed ID: 29263854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine.
    Hao L; Wu Y; Zhang Y; Zhou Z; Lei Q; Ullah N; Banga Ndzouboukou JL; Lin X; Fan X
    Front Immunol; 2020; 11():575504. PubMed ID: 33117374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against
    Jong RM; Van Dis E; Berry SB; Nguyenla X; Baltodano A; Pastenkos G; Xu C; Fox D; Yosef N; McWhirter SM; Stanley SA
    J Immunol; 2022 Jan; 208(2):407-419. PubMed ID: 34965963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses.
    Honda-Okubo Y; Saade F; Petrovsky N
    Vaccine; 2012 Aug; 30(36):5373-81. PubMed ID: 22728225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge.
    Tomar J; Patil HP; Bracho G; Tonnis WF; Frijlink HW; Petrovsky N; Vanbever R; Huckriede A; Hinrichs WLJ
    J Control Release; 2018 Oct; 288():199-211. PubMed ID: 30218687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary immunization with a recombinant influenza A virus vaccine induces lung-resident CD4
    Flórido M; Muflihah H; Lin LCW; Xia Y; Sierro F; Palendira M; Feng CG; Bertolino P; Stambas J; Triccas JA; Britton WJ
    Mucosal Immunol; 2018 Nov; 11(6):1743-1752. PubMed ID: 30115996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.